Loading...
OTCM
HSTC
Market cap42mUSD
Dec 02, Last price  
0.99USD
1D
-1.00%
Jan 2017
1,000.00%
Name

HST Global Inc

Chart & Performance

D1W1MN
OTCM:HSTC chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
16.48%
Rev. gr., 5y
%
Revenues
0k
009,891,09400000000000000000
Net income
-146k
L+0.78%
-78,692-1,139,221-641,81377,301-1,513,333-1,362,612-847,850-540,350-375,923-192,735-184,702-195,795-173,022-165,092-178,335426,572-210,006-151,002-145,074-146,210
CFO
-21k
L-0.61%
-26,856-32,293-925,070-32,754-1,281,706-816,213-327,983-79,268-61,994-38,149-24,550-17,569-21,930-29,874-21,091-91,905-26,971-29,836-21,035-20,906

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
IPO date
Sep 24, 1986
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT